Trump announces trade deal with EU following months of negotiations
Jacqueline Moloney, a director at MKS Instruments Inc. (NASDAQ:MKSI), recently sold 300 shares of the company’s common stock. The sale comes as MKSI trades near its 52-week low of $84.97, with the stock down about 11% in the past week. According to InvestingPro data, technical indicators suggest the stock is currently in oversold territory. The shares were sold at a price of $92.46 each, totaling $27,737. Following this transaction, Moloney holds approximately 9,683 shares directly. This sale was conducted under a Rule 10b5-1 trading plan that Moloney adopted in September 2024. Despite recent price volatility, MKSI maintains strong fundamentals with a 15-year track record of consistent dividend payments. For deeper insights into insider trading patterns and comprehensive analysis, check out the detailed Pro Research Report available on InvestingPro.
In other recent news, MKS Instruments has reported notable financial results and updates. The company revealed strong sales in its Semiconductor and Electronics & Packaging (NYSE:PKG) segments, alongside progress in debt reduction, as highlighted by Benchmark analysts who adjusted their price target to $135 while maintaining a Buy rating. Needham analysts also revised their outlook, lowering the price target to $145 but retaining a Buy rating, noting robust fourth-quarter performance with revenue and earnings per share surpassing expectations. However, guidance for the first-quarter earnings per share fell short, factoring in increased operating expenses and a higher tax rate.
JPMorgan has also adjusted its price target to $135, maintaining an Overweight rating, following MKS Instruments’ December quarter performance, which exceeded expectations. The company’s guidance anticipates a slight revenue decrease for the March quarter, yet shows signs of potential upturns in the NAND and electronics sectors. KeyBanc reaffirmed an Overweight rating with a $160 price target, citing the company’s strong market position and prospects for growth despite some caution regarding specific segments.
Meanwhile, Goldman Sachs slightly raised its price target to $129, maintaining a Neutral rating, following a stock value decline attributed to a tepid earnings forecast. Despite this, the company’s management expressed optimism regarding the Semiconductor business and has taken steps to reduce financial burdens through loan adjustments. These developments reflect a dynamic period for MKS Instruments, with various analysts weighing in on the company’s financial health and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.